AstraZeneca PLC ADR falls on Thursday, with a lower performance on the market

The AstraZeneca PLC ADR AZN,
-1.41%
released 1.41% to $ 50.19 on Thursday, in what proved to be a great global trading session for the stock market, with the NASDAQ Composite Index COMP,
+ 2.56%
rising 2.56% to 13,067.48 and the DIA Jones Industrial Average DJIA,
+ 0.69%
rising 0.69% to 31,041.13. The fall in ADR hit a three-day winning streak. AstraZeneca PLC ADR closed at $ 14.75 below the 52-week high ($ 64.94), which the company hit on July 20th.

The ADR performed lower compared to some of its competitors on Thursday, such as AbbVie Inc. ABBV,
+ 1.07%
rose 1.07% to $ 106.71, Amgen Inc. AMGN,
+ 0.33%
rose 0.33% to $ 234.02 and Gilead Sciences Inc. GILD,
+ 0.92%
increased 0.92% to $ 62.52. The trading volume (13.6 M) overshadowed the 50.2-day average volume of 10.2 M.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. Consult the conditions of use of our market data.

.Source